Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2022 GENTEX CORPORATION (Exact name of registrant as specified in its charter) Michigan 0-10235 38-2030505 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 600 North Centennial Street Zeeland Michigan 49464 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: ( 616 ) 772-1800 _____________________________________________________________ (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.06 per share GNTX NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐      Section 5 – Corporate Governance and Management Item 5.07    Submission of Matters to a Vote of Security Holders. On May 19, 2022, the Company held its 2022 Annual Meeting of the Shareholders.  The matters listed and described briefly below were submitted to a vote of the shareholders through the solicitation of proxies. The proposals are described in detail in the Company's Proxy Statement filed on April 8, 2022.  The voting results are as follows: Election of Directors     The following individuals were elected to serve as directors of the Company to hold office for a one (1) year term expiring in 2023: Nominee Votes For Votes Withheld Broker Non-Votes Mr. Joseph Anderson 187,566,834 3,014,375 17,598,054 Ms. Leslie Brown 185,049,399 5,531,810 17,598,054 Mr. Steve Downing 189,970,329 610,880 17,598,054 Mr. Gary Goode 173,635,027 16,946,182 17,598,054 Mr. James Hollars 189,684,757 896,452 17,598,054 Mr. Richard Schaum 183,676,731 6,904,478 17,598,054 Ms. Kathleen Starkoff 189,753,292 827,917 17,598,054 Mr. Brian Walker 189,692,281 888,928 17,598,054 Dr. Ling Zang 189,265,183 1,316,026 17,598,054 Proposal to Ratify the Appointment of Ernst & Young LLP as the Company's Auditors for the Fiscal Year Ended December 31, 2022     The shareholders did ratify the appointment of Ernst & Young LLP to serve as the Company's auditors for the fiscal year ending December 31, 2022: Votes For Votes Against Abstentions Broker Non-Votes 195,877,000 12,158,955 143,308 Proposal to Approve, on an Advisory Basis, the Compensation of the Company's Named Executive Officers     The shareholders did approve, on an advisory basis, the compensation of the Company's named executive officers: Votes For Votes Against Abstentions Broker Non-Votes 182,672,454 7,527,300 381,455 17,598,054 Proposal to Approve the 2022 Employee Stock Purchase Plan     The shareholders did approve the 2022 Employee Stock Purchase Plan: Votes For Votes Against Abstentions Broker Non-Votes 189,334,864 1,003,896 242,449 17,598,054 SIGNATURE     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Dated: May 24, 2022                            GENTEX CORPORATION                                     (Registrant)                                 By     /s/ Kevin Nash                                     Kevin Nash                                     Chief Financial Officer and                                     Vice President - Finance